Catherine Chang
Overview
Explore the profile of Catherine Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Atkin-Smith G, Santavanond J, Light A, Rimes J, Samson A, Er J, et al.
Nat Commun
. 2024 Oct;
15(1):8802.
PMID: 39438460
Endothelial cells are integral components of all vasculature within complex organisms. As they line the blood vessel wall, endothelial cells are constantly exposed to a variety of molecular factors and...
2.
Romp C, Ross L, Baucom S, Dalmolin B, Chang C
J Healthc Qual
. 2024 Oct;
46(6):359-364.
PMID: 39405522
Background: The Institute for Safe Medication Practices and The Joint Commission recommend the implementation of bidirectional smart infusion pump interoperability with the electronic health record (EHR) to improve medication safety....
3.
Davies N, Francis T, Oldreive C, Azam M, Wilson J, Byrd P, et al.
Haematologica
. 2024 Jun;
109(12):3989-4006.
PMID: 38841800
Diffuse large B-cell lymphoma (DLBCL) is the most common malignancy that develops in patients with ataxia-telangiectasia, a cancer-predisposing inherited syndrome characterized by inactivating germline ATM mutations. ATM is also frequently...
4.
Diepstraten S, Yuan Y, La Marca J, Young S, Chang C, Whelan L, et al.
Cancer Cell
. 2024 Apr;
42(5):850-868.e9.
PMID: 38670091
TP53-mutant blood cancers remain a clinical challenge. BH3-mimetic drugs inhibit BCL-2 pro-survival proteins, inducing cancer cell apoptosis. Despite acting downstream of p53, functional p53 is required for maximal cancer cell...
5.
Han P, Chang C, Yemane L, Jackson J, Omoruyi E, Umoren R
Acad Pediatr
. 2023 Dec;
24(2):197-198.
PMID: 38135249
No abstract available.
6.
La Marca J, Aubrey B, Yang B, Chang C, Wang Z, Kueh A, et al.
Cell Death Differ
. 2023 Dec;
31(2):150-158.
PMID: 38097622
Whole-genome screens using CRISPR technologies are powerful tools to identify novel tumour suppressors as well as factors that impact responses of malignant cells to anti-cancer agents. Applying this methodology to...
7.
Wang Z, Burigotto M, Ghetti S, Vaillant F, Tan T, Capaldo B, et al.
Cancer Discov
. 2023 Oct;
14(2):362-379.
PMID: 37877779
Significance: This study provides evidence that removal of mutant TP53, thereby deleting its reported GOF activities, does not impact the survival, proliferation, metastasis, or chemotherapy responses of cancer cells. Thus,...
8.
Wen S, Ou-Yang C, Chang C, Chen C, Chang H
Acta Derm Venereol
. 2023 Oct;
103:adv9400.
PMID: 37787418
Type 2 diabetes is associated with an increased risk of herpes zoster and postherpetic neuralgia. However, the association of type 1 diabetes with herpes zoster or postherpetic neuralgia remains unclear....
9.
Purington C, Eilevstjonn J, Dalen I, Yeconia A, Blacy L, Mduma E, et al.
Children (Basel)
. 2023 Sep;
10(9).
PMID: 37761501
Suctioning of newborns immediately after birth, as part of delivery room resuscitation, is only recommended if the airway is obstructed. The aim of this study was to describe the use...
10.
Diepstraten S, La Marca J, Chang C, Young S, Strasser A, Kelly G
Oncogene
. 2023 Aug;
42(37):2776-2781.
PMID: 37567974
The BH3-mimetic drug Venetoclax, a specific inhibitor of anti-apoptotic BCL-2, has had clinical success for the treatment of chronic lymphocytic leukaemia and acute myeloid leukaemia. Attention has now shifted towards...